Delivery Order SPE2DB22D9367-SPE2DB25FSX12
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $42,891.80 by the Defense Logistics Agency on August 7, 2025, for the supply of ICLUSIG 45 mg tablets (30-count units). The contract, which carries no set-aside designation, is scheduled for completion by August 28, 2025, and represents a targeted pharmaceutical delivery to support federal healthcare operations. This award is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $43.3K for ICLUSIG 30 mg tablets (30-count units) from the Medical Supply Chain, a defense-focused federal agency. This award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, is a firm fixed-price delivery order with no set-aside designation. The contract represents a single award under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $171,788.80 on August 20, 2025, for the supply of Iclusig 30 mg tablets (30-count packages). The contract, with an ultimate completion date of September 11, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain program and carries no set-aside designation. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $55,179.60 to DMS Pharmaceutical Group Inc. for the supply of Iclusig 15 mg tablets (30-count units) on September 22, 2025. The award is structured as a firm fixed-price delivery order with an ultimate completion date of October 14, 2025, and represents no specific set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery...
- The Defense Logistics Agency awarded a $42,592.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 30 tablets of Iclusig 15 mg. The contract, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $42,592.16 by the Defense Logistics Agency (DLA) on July 14, 2025, with an ultimate completion date of August 4, 2025. The delivery order, contract number 4568823267, covers the supply of Iclusig 15 mg tablets (30-count units), a specialty oncology medication. This award was issued without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $85,894.40 on August 11, 2025, for the supply of ICLUSIG 30 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, was issued under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program and is funded through the Defense Department's Medical Supply Chain....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,870.16 contract is for the supply of the drug Iclusig 15 mg tablet in 30-count packages, with a completion date of November 19, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,445.90 contract is for the delivery of ICLUSIG 45 MG TABLET 30S, a specialized pharmaceutical product, with a period of performance through February 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $21,651.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ICLUSIG 30 mg tablets (30-count). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was awarded on August 29, 2025. This award does not utilize a set-aside designation, allowing the vendor to compete on an open...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSX12Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $42,592.16 for the supply of Iclusig 15 mg tablets (30-count units) by the Defense Logistics Agency on March 12, 2025. This firm fixed-price delivery order, with an ultimate completion date of April 2, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 million single-award vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive pharmaceutical supplies supporting military healthcare facilities nationwide. Iclusig (ponatinib) is a tyrosine kinase inhibitor used in oncology treatments, consistent with DMS Pharmaceutical Group's demonstrated portfolio of specialty pharmaceutical products delivered to federal healthcare systems. The company's established position as a critical supplier within the federal pharmaceutical supply chain, combined with its SAM.gov registration since 2001, reinforces its capability to reliably distribute branded prescription drugs and specialty medications to Department of Defense healthcare sites. This delivery order represents one of numerous routine pharmaceutical procurement actions executed under the broader SPE2DB indefinite delivery framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.6k | 3/12/25 |